Press release from Companies: The Covid-19 pandemic is expected to further affect RhoVac’s clinical phase IIb study

Press release from Companies: Covid-19-pandemin förväntas påverka RhoVac’s kliniska fas IIb-studie ytterligare

Press release from Companies: Covid-19-pandemin förväntas påverka RhoVac’s kliniska fas IIb-studie ytterligare

Press release from Companies: First patient in treatment in RhoVac's clinical phase IIb study in Sweden

Press release from Companies: Första patienten i behandling i RhoVacs kliniska fas IIb-studie i Sverige

Press release from Companies: Första patienten i behandling i RhoVacs kliniska fas IIb-studie i Sverige

Press release from Companies: RhoVac appoints Professor Georg Holländer to its Scientific Advisory Board

Press release from Companies: RhoVac rekryterar professor Georg Holländer till sitt vetenskapliga råd

Reports: RhoVac AB presenterar delårsrapport Q2 2020

Press release from Companies: First patient in treatment in RhoVac's clinical phase IIb study in the USA

Press release from Companies: Första patienten i behandling i RhoVacs kliniska fas IIb-studie i USA

More from the company: A RhoVac article is published in the June edition of MedNous, a publication of Evernow Publishing Ltd